Proteomic approaches in brain research and neuropharmacology
Authors:
- John J.M. BergeronJBJohn J.M. Bergeron
- Frans VandesandeFVFrans Vandesande
- Rémi QuirionRQRémi Quirion
- 1 October 2004
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 500 (1-3) , 385-398
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- PeptidomicsJournal of Chromatography B, 2004
- Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brainBrain Research, 2004
- Organelle proteomics: looking at less to see moreTrends in Cell Biology, 2003
- Bioinformatics: Programmed for successNature, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortexProteomics, 2002
- Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategiesProgress in Neurobiology, 2002
- Protein oxidation in the brain in Alzheimer's diseaseNeuroscience, 2001
- A comparison of selected mRNA and protein abundances in human liverElectrophoresis, 1997
- Electrophysiological characterization of diazepam binding inhibitor (DBI) on GABAA receptorsNeuropharmacology, 1991